The Muscular Dystrophy Association applauds the United States Senate for passing the House’s version of the ACT for ALS ...

Annual campaign gives shoppers an opportunity to turn everyday purchases into meaningful impact for people living with muscular dystrophy, ALS and related neuromuscular diseases. NEW YORK – Wednesday, ...

A weekend to recharge, connect, and make memories—together. Family Getaways provide a unique recreation experience that promotes fun, independence, and adventure for individuals living with ...

MDA Virtual Summer camp provides an engaging and meaningful experience for kids and young adults who prefer to experience the joys of Camp from the comfort of their homes. Outfitted with a Supply Kit ...

The 26th Annual MDA Wings Over Wall Street Gala to Benefit ALS Research will take place on Thursday, June 4, hosted by Bill Ritter, ABC7 New York Eyewitness News. Dr. Merit Cudkowicz with Tim Green ...

The MDA Muscle Walk is an inspiring event that unites communities throughout the country behind the mission to empower people living with neuromuscular diseases to live life to the fullest potential.

Multidisciplinary care, including neuromuscular, cardiac, respiratory, endocrine, endocrinologic, nutritional, psychosocial, and orthopedic management, is recommended for people with DMD in order to ...

Join leading clinicians and researchers at MDA’s Clinical & Scientific Conference, March 8–11, 2026, in Orlando, FL. Learn more and register for the world’s most talked-about gathering of leading ...

Join us for a powerful and informative webinar focused on the unique needs and challenges of weight management with neuromuscular disease. Whether you're a patient, caregiver, or advocate, this ...

MDA is proud to offer the Durable Medical Equipment (DME) Grant to help children and adults living with neuromuscular diseases get the equipment they need to live more independently and comfortably.

New York, March 10, 2025 – The Muscular Dystrophy Association (MDA) welcomes the U.S. Food and Drug Administration (FDA) approval of the expanded indication of Alexion/AstraZeneca’s eculizumab ...